Patents Assigned to PEGASUS LABORATORIES, INC.
  • Amphipathic lipid-based sustained release compositions
    Patent number: 10722458
    Abstract: Chewable sustained release compositions and their methods of production are provided. The sustained release compositions contain amphipathic lipids and matrix-forming polymers, which are used to encapsulate various drugs and active ingredients. The chewable sustained release compositions can maintain their sustained release properties even after being fragmented into a plurality of pieces.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: July 28, 2020
    Assignee: Pegasus Laboratories, Inc.
    Inventors: Scott A. Howard, Troy Purvis
  • Amphipathic lipid-based sustained release compositions
    Patent number: 9248096
    Abstract: Chewable sustained release compositions and their methods of production are provided. The sustained release compositions contain amphipathic lipids, which are used to encapsulate various drugs and active ingredients.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: February 2, 2016
    Assignee: PEGASUS LABORATORIES, INC.
    Inventors: Scott A. Howard, Troy Purvis
  • AMPHIPATHIC LIPID-BASED SUSTAINED RELEASE COMPOSITIONS
    Publication number: 20130142876
    Abstract: Chewable sustained release compositions and their methods of production are provided. The sustained release compositions contain amphipathic lipids, which are used to encapsulate various drugs and active ingredients.
    Type: Application
    Filed: November 30, 2012
    Publication date: June 6, 2013
    Applicant: PEGASUS LABORATORIES, INC.
    Inventor: Pegasus Laboratories, Inc.